Boston Scientific Corporation (NYSE:BSX) Q1 2024 Earnings Call Transcript

Boston Scientific Corporation ... majority stake investment in Acotec Scientific Holdings Limited and the acquisitions of Apollo Endosurgery and Relievant Medsystems, which closed in February, April ... Read More

Boston Scientific: Strong Q1 Performance and Promising Future Drive Buy Rating

Analyst Travis Steed of Bank of America Securities reiterated a Buy rating on Boston Scientific (BSX – Research Report), with a price ... Read More

Boston Scientific Beats Forecasts, Boosts Outlook on Booming Heart Device Sales

Shares of Boston Scientific ( BSX) hit an all-time high Wednesday as the maker of medical equipment reported better-than-anticipated quarterly results and boosted its guidance on demand for its ... Read More

Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst

Both Medtronic and Boston Scientific had shown previous interest in acquiring Shockwave Medical. Shockwave Medical is a cardiovascular medical device. In 2022, Johnson & Johnson acquired heart ... Read More

Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash

Boston Scientific expects 8-10% sales growth in their 2024-2026 guidance, which already includes short-term upsides such as FARAPULSE’s recent FDA approval. The legal clash between Axonics and ... Read More

Boston Scientific’s stock heads for record high as earnings shine and company offers upbeat guidance

Boston Scientific Corp.’s stock rose 7% Wednesday to put it on track for a fresh record high after the medical-tech company beat analyst estimates for first-quarter earnings and offered upbeat ... Read More

Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info on $3.7B deal

Boston Scientific agreed to acquire the med-tech firm for $71 per share in cash in January. The ~$3.7B deal was previously expected to be complete in the first half of 2024. Shares of Axonics ... Read More

EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS

2 Eurobio Scientific's annual results for 2023 reflect both the end of the COVID business, partly offset by strong growth in the core business, and the strategic transformation underway ... Read More

Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics

Wall Street analysts expect Boston ... company's key metrics can offer a more comprehensive perspective. Bearing this in mind, let's now explore the average estimates of specific Boston Scientific ... Read More

Heart Disease News

a groundbreaking new tool -- a comprehensive software that automates the analysis of heart cell function from video data. It's the first system to integrate the ... Stopping Aspirin One Month ... Read More